Tobias Hestler Insider Profile
4 Followers
Tobias Hestler, Director at Hikma Pharmaceuticals, holds ― shares in Hikma Pharmaceuticals (Ticker: GB:HIK), holds ― shares in ConvaTec (Ticker: GB:CTEC), holds 38.56K shares in Haleon PLC (Ticker: GB:HLN). Most recently, Tobias Hestler Bought ― shares of Hikma Pharmaceuticals on Aug 11, 2026 for an estimated value of 123.60K .
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-12.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tobias Hestler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tobias Hestler
Tobias Hestler's Trading History
Hikma Pharmaceuticals
Aug 11, 2026
Director
Informative Buy
123.60K
―
Haleon PLC
May 24, 2024
Chief Financial Officer
Uninformative Buy
1.55K
£131.18K
ConvaTec
Aug 07, 2026
Director
Informative Buy
112.90K
―
List of latest transactions for each holding click on a transaction to see Tobias Hestler's performance on stock
You May Also Like
Tobias Hestler insider profile FAQ
What is the percentage of profitable transactions made by Tobias Hestler?
The percentage of profitable transactions made by Tobias Hestler is 0%.
What is the average return per transaction made by Tobias Hestler?
The average return per transaction made by Tobias Hestler is -12.30%.
What stocks does Tobias Hestler hold?
Tobias Hestler holds: GB:HIK, GB:HLN, GB:CTEC stocks.
What was Tobias Hestler’s latest transaction?
Tobias Hestler latest transaction was an Informative Buy of 123.60K .
What was Tobias Hestler's most profitable transaction?
Tobias Hestler’s most profitable transaction was an Informative Buy of GB:HIK stock on August 11, 2026. The return on the trade was -1.20%.
What is Tobias Hestler's role in Hikma Pharmaceuticals?
Tobias Hestler's role in Hikma Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.